Karmali, R., Shouse, G., Torka, P., Moyo, T. K., Romancik, J., Barta, S. K., Bhansali, R., Cohen, J. B., Shah, N. N., Zurko, J., Kenkre, V. P., Hess, B., Stephens, D. M., Fitzgerald, L., Ollila, T., Tabiti, B., Roy, I., Ma, S., Winter, J., … Epperla, N. (2025). Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy. Blood Cancer Journal, 15(1). https://doi.org/10.1038/s41408-025-01250-8

Mohan, M., Monge, J., Shah, N., Luan, D., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al-Hadidi, S., Cooper, D., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2024). Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-01003-z

Neupane, K., Fortuna, G. G., Dahal, R., Schmidt, T., Fonseca, R., Chakraborty, R., Koehn, K. A., Mohan, M., Mian, H., Costa, L. J., Sborov, D., & Mohyuddin, G. R. (2024). Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-00985-0

Kumar, S., Baizer, L., Callander, N. S., Giralt, S. A., Hillengass, J., Freidlin, B., Hoering, A., Richardson, P. G., Schwartz, E. I., Reiman, A., Lentzsch, S., McCarthy, P. L., Jagannath, S., Yee, A. J., Little, R. F., & Raje, N. S. (2022). Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood Cancer Journal, 12(6). https://doi.org/10.1038/s41408-022-00695-5

Albitar, M., Zhang, H., Goy, A., Xu-Monette, Z. Y., Bhagat, G., Visco, C., Tzankov, A., Fang, X., Zhu, F., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., … Young, K. H. (2022). Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer Journal, 12(2). https://doi.org/10.1038/s41408-022-00617-5

Fernández de Larrea, C., Kyle, R., Rosiñol, L., Paiva, B., Engelhardt, M., Usmani, S., Caers, J., Gonsalves, W., Schjesvold, F., Merlini, G., Lentzch, S., Ocio, E., Garderet, L., Moreau, P., Sonneveld, P., Badros, A., Gahrton, G., Goldschmidt, H., Tuchman, S., … Mateos, M. V. (2021). Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer Journal, 11(12). https://doi.org/10.1038/s41408-021-00587-0